## Core Concept
Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by inflammation and fibrosis of the intrahepatic and extrahepatic bile ducts, leading to cholestasis and potentially cirrhosis. The exact cause of PSC is unknown, but it is strongly associated with inflammatory bowel disease (IBD), particularly ulcerative colitis. PSC is more common in males.

## Why the Correct Answer is Right
The correct answer, ., implies that the statement regarding PSC being associated with an increased risk of cholangiocarcinoma is indeed true. PSC patients have a significantly increased risk of developing cholangiocarcinoma, which is a type of cancer that arises from the bile duct epithelium. This association is well-documented and is a critical consideration in the management of patients with PSC.

## Why Each Wrong Option is Incorrect
- **Option A:** If option A states a characteristic not typical of PSC or not associated with PSC, it would be incorrect. For instance, if it suggests PSC is more common in females, this would be wrong as PSC is more common in males.
- **Option B:** Similarly, if option B mentions a feature not commonly linked with PSC, such as a specific genetic mutation not typically associated with the disease, it would be considered incorrect.
- **Option C:** If option C proposes a treatment or management strategy not aligned with current practices for PSC, it would be incorrect. PSC management primarily involves monitoring, management of symptoms, and potentially liver transplantation in advanced cases.

## Clinical Pearl / High-Yield Fact
A key clinical pearl for PSC is its strong association with ulcerative colitis, a form of IBD. Patients with PSC are at an increased risk of developing colorectal cancer, particularly if they also have ulcerative colitis. Therefore, regular screening for colorectal cancer is recommended in these patients.

## Correct Answer: D.